Anne Olson
About Anne Olson
Anne Olson, age 48, is an independent director of CareTrust REIT, Inc. (CTRE) since 2022. She is President, Chief Executive Officer and a Trustee of Centerspace (NYSE:CSR), with prior roles as COO/Secretary (2018–Mar 2023) and EVP/General Counsel/Secretary (2017–2018) at CSR; earlier, she practiced law at Dorsey & Whitney focused on REIT transactions and served at Welsh Companies (predecessor to WPT Industrial REIT). She holds a B.A. and J.D. from Drake University and has been designated an “audit committee financial expert” under SEC rules .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Centerspace (NYSE:CSR) | President, CEO & Trustee | Current (CEO/Trustee); COO & Secretary (2018–Mar 2023); EVP, General Counsel & Secretary (2017–2018) | Executive leadership of public REIT; governance and legal oversight |
| Dorsey & Whitney LLP | Partner, Real Estate Practice Group | 2011–2017 | Real estate development and investments for REITs and PE funds |
| Welsh Companies, LLC (predecessor to WPT Industrial REIT) | Director of Investment Operations & in-house counsel | 2006–2011 | Investment operations and legal counsel for real estate platform |
External Roles
| Organization | Position | Focus/Notes |
|---|---|---|
| Centerspace (NYSE:CSR) | Trustee (board) | Public multifamily REIT; Olson is also CEO |
| National Multifamily Housing Council (NMHC) | Vice Chair, Innovation Committee | Industry leadership and innovation agenda for multifamily sector |
| Urban Land Institute (ULI) | Active Member | Industry network and best practices engagement |
Board Governance
- Independence: The Board determined Ms. Olson (non-employee) is independent under NYSE rules .
- Committee assignments and leadership (2024):
- Nominating & Corporate Governance Committee – Chair
- Audit Committee – Member; designated “audit committee financial expert” by the Board
- Sustainability & Corporate Responsibility (SCR) Committee – Member
- Meetings and engagement:
- Board met 5 times in 2024; each director attended at least 75% of Board and applicable committee meetings; all directors attended the 2024 annual meeting .
- Independent directors meet regularly in executive session, chaired by the independent Board Chair .
- Committee meeting cadence in 2024: Audit (4), Compensation (6), Nominating & Corporate Governance (3), SCR (4) .
Fixed Compensation (Director)
| Component | Amount | Notes |
|---|---|---|
| Annual cash retainer (Board member) | $80,000 | Effective 2024 after increase approved by Board |
| Chair fee – Nominating & Corporate Governance | $20,000 | Chair retainer for committee leadership |
| Fees earned/paid in cash (2024 actual) | $100,000 | As reported for Anne Olson |
| Annual equity grant (restricted stock) | $130,000 | Grant date value; increased beginning with 2024 annual meeting |
| Total 2024 director compensation | $230,000 | $100,000 cash + $130,000 stock |
| Vesting for annual director RS | — | Vests in full on earlier of first anniversary of grant or next annual meeting, subject to service |
| Election to take fees in stock | — | Directors may elect to convert cash fees into RS (1-year vest) |
Performance Compensation (Director)
- Non-employee director equity is time-based restricted stock (not performance-based); no director performance metrics disclosed or used for annual board pay .
Other Directorships & Interlocks
| Company | Role | Interlock/Conflict Notes |
|---|---|---|
| Centerspace (NYSE:CSR) | CEO & Trustee | CareTrust discloses no related-person transactions since Jan 1, 2024; Audit Committee reviews any such transactions per policy |
| CareTrust Compensation Committee Interlocks | N/A | Compensation Committee members in 2024 were Plumb (Chair), Laing, Williams; no interlocks disclosed |
Expertise & Qualifications
- Audit and financial expertise: Board determined Ms. Olson qualifies as an “audit committee financial expert” (SEC definition) .
- REIT transactions and legal/governance proficiency: Extensive experience structuring complex real estate transactions and advising public companies .
- Executive leadership: CEO of a public REIT; prior COO and GC roles at CSR .
- Industry leadership: Vice Chair of NMHC Innovation Committee; active in ULI .
- Education: B.A. (English), J.D., Drake University .
Equity Ownership
| Metric | Detail |
|---|---|
| Common shares beneficially owned | 12,690 shares |
| Unvested restricted stock (time-based) | 5,428 shares (held as of 12/31/2024) |
| Total beneficial ownership (incl. RS) | 18,118 shares |
| Ownership as % of outstanding | <1% (denoted “*”) |
| Director ownership guideline | ≥6x annual cash retainer; retain 50% of net-after-tax shares until in compliance |
| Compliance status | All non-employee directors either met the requirement or are within the five-year compliance window as of 12/31/2024 |
| Hedging/pledging | Hedging prohibited; pledging/margin requires preclearance for directors, officers, employees |
Related-Party & Insider Transactions
- Related-person transactions: None requiring disclosure since January 1, 2024 (covering directors and immediate family) .
- Approval policy: Audit Committee must pre-approve related-person transactions; interested directors recuse .
Say-on-Pay & Shareholder Signals (Context for Governance)
- Say-on-pay support was >96.5% at the 2024 annual meeting; strong historical support since 2017 .
Governance Assessment
- Strengths
- Independent director with deep REIT operating, legal, and governance experience; designated audit committee financial expert .
- Engagement indicators are solid: ≥75% attendance; active committee leadership (Chair, Nominating & Corporate Governance) and service on Audit and SCR committees .
- Alignment mechanisms: mandatory stock ownership (6x retainer), option to take fees in stock, anti-hedging/pledging policy .
- No related-person transactions disclosed; robust audit committee oversight of such matters .
- Watch items
- External time commitments: Serving as CEO and Trustee of CSR could pose bandwidth considerations, though CareTrust reports director attendance thresholds were met in 2024 .
- Interlocks: None disclosed for compensation committee; continue monitoring for any future cross-board roles or transactions with CSR; none reported for 2024 .
Overall: Olson’s profile aligns with investor-preferred governance—independence, financial expertise, active committee leadership, equity alignment, and no related-party exposure disclosed. These factors generally support board effectiveness and investor confidence at CTRE .